APO Research

APO RESEARCH · REPORT

Nasal Spray Flu Vaccines

Selected research

Industry Growth & Trends

Global Nasal Spray Flu Vaccines Industry Growth and Trends Forecast to 2032

Market perspective

The global Nasal Spray Flu Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nasal Spray Flu Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nasal Spray Flu Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nasal Spray Flu Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nasal Spray Flu Vaccines include Abbott, GlaxoSmithKline, AstraZeneca, Serum Institute of India, Sanofi Pasteur and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nasal Spray Flu Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nasal Spray Flu Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nasal Spray Flu Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nasal Spray Flu Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nasal Spray Flu Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nasal Spray Flu Vaccines Market by Company

Abbott

GlaxoSmithKline

AstraZeneca

Serum Institute of India

Sanofi Pasteur

CSL

Nasal Spray Flu Vaccines Segment by Type

Trivalent Flu Vaccine

Quadrivalent Flu Vaccine

Nasal Spray Flu Vaccines Segment by Application

Clinic

Hospital

Public Health Agency

Other

Nasal Spray Flu Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Spray Flu Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Spray Flu Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Spray Flu Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nasal Spray Flu Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nasal Spray Flu Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Trivalent Flu Vaccine Table 2. Major Company of Quadrivalent Flu Vaccine Table 3. Global Nasal Spray Flu Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (k doses) Table 5. Global Nasal Spray Flu Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Nasal Spray Flu Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Nasal Spray Flu Vaccines Price by Type (2021-2026) & (US$/dose) Table 9. Global Nasal Spray Flu Vaccines Sales by Type (2027-2032) & (k doses) Table 10. Global Nasal Spray Flu Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Nasal Spray Flu Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Nasal Spray Flu Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Nasal Spray Flu Vaccines Price by Type (2027-2032) & (US$/dose) Table 14. North America Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (k doses) Table 15. North America Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (k doses) Table 17. Europe Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (k doses) Table 19. Asia-Pacific Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (k doses) Table 21. Latin America Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (k doses) Table 23. Middle East and Africa Nasal Spray Flu Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Nasal Spray Flu Vaccines Industry Trends Table 25. Nasal Spray Flu Vaccines Industry Drivers Table 26. Nasal Spray Flu Vaccines Industry Opportunities and Challenges Table 27. Nasal Spray Flu Vaccines Industry Restraints Table 28. Global Nasal Spray Flu Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Nasal Spray Flu Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Nasal Spray Flu Vaccines Sales by Company (2021-2026) & (k doses) Table 31. Global Nasal Spray Flu Vaccines Sales Share by Company (2021-2026) Table 32. Global Nasal Spray Flu Vaccines Market Price by Company (2021-2026) & (US$/dose) Table 33. Global Nasal Spray Flu Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nasal Spray Flu Vaccines Major Company Production Sites and Headquarters Table 35. Global Nasal Spray Flu Vaccines Company, Product Type & Application Table 36. Global Nasal Spray Flu Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Nasal Spray Flu Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nasal Spray Flu Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Nasal Spray Flu Vaccines Sales by Region (2021-2026) & (k doses) Table 41. Global Nasal Spray Flu Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Nasal Spray Flu Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Nasal Spray Flu Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Nasal Spray Flu Vaccines Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 45. Global Nasal Spray Flu Vaccines Sales by Region (2027-2032) & (k doses) Table 46. Global Nasal Spray Flu Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Nasal Spray Flu Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Nasal Spray Flu Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Nasal Spray Flu Vaccines Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2027-2032) Table 50. Global Nasal Spray Flu Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (k doses) Table 52. Global Nasal Spray Flu Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Nasal Spray Flu Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Nasal Spray Flu Vaccines Price by Application (2021-2026) & (US$/dose) Table 56. Global Nasal Spray Flu Vaccines Sales by Application (2027-2032) & (k doses) Table 57. Global Nasal Spray Flu Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Nasal Spray Flu Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Nasal Spray Flu Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Nasal Spray Flu Vaccines Price by Application (2027-2032) & (US$/dose) Table 61. North America Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (k doses) Table 62. North America Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (k doses) Table 64. Europe Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (k doses) Table 66. Asia-Pacific Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (k doses) Table 68. Latin America Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (k doses) Table 70. Middle East and Africa Nasal Spray Flu Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Abbott Company Information Table 72. Abbott Business Overview Table 73. Abbott Nasal Spray Flu Vaccines Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 74. Abbott Nasal Spray Flu Vaccines Product Portfolio Table 75. Abbott Recent Development Table 76. GlaxoSmithKline Company Information Table 77. GlaxoSmithKline Business Overview Table 78. GlaxoSmithKline Nasal Spray Flu Vaccines Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 79. GlaxoSmithKline Nasal Spray Flu Vaccines Product Portfolio Table 80. GlaxoSmithKline Recent Development Table 81. AstraZeneca Company Information Table 82. AstraZeneca Business Overview Table 83. AstraZeneca Nasal Spray Flu Vaccines Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 84. AstraZeneca Nasal Spray Flu Vaccines Product Portfolio Table 85. AstraZeneca Recent Development Table 86. Serum Institute of India Company Information Table 87. Serum Institute of India Business Overview Table 88. Serum Institute of India Nasal Spray Flu Vaccines Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 89. Serum Institute of India Nasal Spray Flu Vaccines Product Portfolio Table 90. Serum Institute of India Recent Development Table 91. Sanofi Pasteur Company Information Table 92. Sanofi Pasteur Business Overview Table 93. Sanofi Pasteur Nasal Spray Flu Vaccines Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 94. Sanofi Pasteur Nasal Spray Flu Vaccines Product Portfolio Table 95. Sanofi Pasteur Recent Development Table 96. CSL Company Information Table 97. CSL Business Overview Table 98. CSL Nasal Spray Flu Vaccines Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 99. CSL Nasal Spray Flu Vaccines Product Portfolio Table 100. CSL Recent Development Table 101. North America Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 102. North America Nasal Spray Flu Vaccines Sales by Country (2021-2026) & (k doses) Table 103. North America Nasal Spray Flu Vaccines Sales Market Share by Country (2021-2026) Table 104. North America Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032) & (k doses) Table 105. North America Nasal Spray Flu Vaccines Sales Market Share Forecast by Country (2027-2032) Table 106. North America Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Nasal Spray Flu Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Nasal Spray Flu Vaccines Market Share by Country (2021-2026) Table 109. North America Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Nasal Spray Flu Vaccines Market Share Forecast by Country (2027-2032) Table 111. Europe Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 112. Europe Nasal Spray Flu Vaccines Sales by Country (2021-2026) & (k doses) Table 113. Europe Nasal Spray Flu Vaccines Sales Market Share by Country (2021-2026) Table 114. Europe Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032) & (k doses) Table 115. Europe Nasal Spray Flu Vaccines Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Nasal Spray Flu Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Nasal Spray Flu Vaccines Market Share by Country (2021-2026) Table 119. Europe Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Nasal Spray Flu Vaccines Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Nasal Spray Flu Vaccines Sales by Country (2021-2026) & (k doses) Table 123. Asia-Pacific Nasal Spray Flu Vaccines Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032) & (k doses) Table 125. Asia-Pacific Nasal Spray Flu Vaccines Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Nasal Spray Flu Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Nasal Spray Flu Vaccines Market Share by Country (2021-2026) Table 129. Asia-Pacific Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Nasal Spray Flu Vaccines Market Share Forecast by Country (2027-2032) Table 131. Latin America Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 132. Latin America Nasal Spray Flu Vaccines Sales by Country (2021-2026) & (k doses) Table 133. Latin America Nasal Spray Flu Vaccines Sales Market Share by Country (2021-2026) Table 134. Latin America Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032) & (k doses) Table 135. Latin America Nasal Spray Flu Vaccines Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Nasal Spray Flu Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Nasal Spray Flu Vaccines Market Share by Country (2021-2026) Table 139. Latin America Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Nasal Spray Flu Vaccines Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Nasal Spray Flu Vaccines Sales by Country (2021-2026) & (k doses) Table 143. Middle East and Africa Nasal Spray Flu Vaccines Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032) & (k doses) Table 145. Middle East and Africa Nasal Spray Flu Vaccines Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Nasal Spray Flu Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Nasal Spray Flu Vaccines Market Share by Country (2021-2026) Table 149. Middle East and Africa Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Nasal Spray Flu Vaccines Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Nasal Spray Flu Vaccines Distributors List Table 154. Nasal Spray Flu Vaccines Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Nasal Spray Flu Vaccines Image Figure 2. Global Nasal Spray Flu Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nasal Spray Flu Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Nasal Spray Flu Vaccines Sales (2021-2032) & (k doses) Figure 5. Trivalent Flu Vaccine Image Figure 6. Global Trivalent Flu Vaccine Sales YoY Growth (2021-2032) & (k doses) Figure 7. Quadrivalent Flu Vaccine Image Figure 8. Global Quadrivalent Flu Vaccine Sales YoY Growth (2021-2032) & (k doses) Figure 9. Global Nasal Spray Flu Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Nasal Spray Flu Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Nasal Spray Flu Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Nasal Spray Flu Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Nasal Spray Flu Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Nasal Spray Flu Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Nasal Spray Flu Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Nasal Spray Flu Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Nasal Spray Flu Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Nasal Spray Flu Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Nasal Spray Flu Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Nasal Spray Flu Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Nasal Spray Flu Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinic Image Figure 24. Global Clinic Sales YoY Growth (2021-2032) & (k doses) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k doses) Figure 27. Public Health Agency Image Figure 28. Global Public Health Agency Sales YoY Growth (2021-2032) & (k doses) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (k doses) Figure 31. Global Nasal Spray Flu Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Nasal Spray Flu Vaccines Market Share by Application 2025 VS 2032 Figure 33. North America Nasal Spray Flu Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. North America Nasal Spray Flu Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Europe Nasal Spray Flu Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Europe Nasal Spray Flu Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Nasal Spray Flu Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Nasal Spray Flu Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Latin America Nasal Spray Flu Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Nasal Spray Flu Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Nasal Spray Flu Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Nasal Spray Flu Vaccines Sales Market Share in Value by Application in 2025 Figure 43. North America Nasal Spray Flu Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 44. North America Nasal Spray Flu Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Nasal Spray Flu Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Nasal Spray Flu Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nasal Spray Flu Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 48. Europe Nasal Spray Flu Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nasal Spray Flu Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Nasal Spray Flu Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Nasal Spray Flu Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 52. Asia-Pacific Nasal Spray Flu Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Nasal Spray Flu Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Nasal Spray Flu Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nasal Spray Flu Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 56. Latin America Nasal Spray Flu Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Nasal Spray Flu Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Nasal Spray Flu Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Nasal Spray Flu Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 60. Middle East and Africa Nasal Spray Flu Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Nasal Spray Flu Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Nasal Spray Flu Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Nasal Spray Flu Vaccines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Nasal Spray Flu Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Trivalent Flu Vaccine
  • Quadrivalent Flu Vaccine
Applications
  • Clinic
  • Hospital
  • Public Health Agency
  • Other
Companies covered
  • Abbott
  • GlaxoSmithKline
  • AstraZeneca
  • Serum Institute of India
  • Sanofi Pasteur
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nasal Spray Flu Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nasal Spray Flu Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nasal Spray Flu Vaccines Market by Type
  6. 1.3.1 Trivalent Flu Vaccine
  7. 1.3.2 Quadrivalent Flu Vaccine
  8. 1.4 Global Nasal Spray Flu Vaccines Market Size by Type
  9. 1.4.1 Global Nasal Spray Flu Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Nasal Spray Flu Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Nasal Spray Flu Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Nasal Spray Flu Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Nasal Spray Flu Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Nasal Spray Flu Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Nasal Spray Flu Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Nasal Spray Flu Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nasal Spray Flu Vaccines Industry Trends
  2. 2.2 Nasal Spray Flu Vaccines Industry Drivers
  3. 2.3 Nasal Spray Flu Vaccines Industry Opportunities and Challenges
  4. 2.4 Nasal Spray Flu Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nasal Spray Flu Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Nasal Spray Flu Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Nasal Spray Flu Vaccines Price (2021-2026)
  4. 3.4 Global Nasal Spray Flu Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nasal Spray Flu Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Nasal Spray Flu Vaccines Company, Product Type & Application
  7. 3.7 Global Nasal Spray Flu Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nasal Spray Flu Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nasal Spray Flu Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nasal Spray Flu Vaccines Tier 1, Tier 2, and Tier 3
4 Nasal Spray Flu Vaccines Regional Status and Outlook
  1. 4.1 Global Nasal Spray Flu Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nasal Spray Flu Vaccines Historic Market Size by Region
  3. 4.2.1 Global Nasal Spray Flu Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nasal Spray Flu Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nasal Spray Flu Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nasal Spray Flu Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Nasal Spray Flu Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nasal Spray Flu Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nasal Spray Flu Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nasal Spray Flu Vaccines by Application
  1. 5.1 Nasal Spray Flu Vaccines Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Public Health Agency
  5. 5.1.4 Other
  6. 5.2 Global Nasal Spray Flu Vaccines Market Size by Application
  7. 5.2.1 Global Nasal Spray Flu Vaccines Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Nasal Spray Flu Vaccines Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Nasal Spray Flu Vaccines Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Nasal Spray Flu Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Nasal Spray Flu Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Nasal Spray Flu Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Nasal Spray Flu Vaccines Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Nasal Spray Flu Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Nasal Spray Flu Vaccines Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 GlaxoSmithKline
  8. 6.2.1 GlaxoSmithKline Company Information
  9. 6.2.2 GlaxoSmithKline Business Overview
  10. 6.2.3 GlaxoSmithKline Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GlaxoSmithKline Nasal Spray Flu Vaccines Product Portfolio
  12. 6.2.5 GlaxoSmithKline Recent Developments
  13. 6.3 AstraZeneca
  14. 6.3.1 AstraZeneca Company Information
  15. 6.3.2 AstraZeneca Business Overview
  16. 6.3.3 AstraZeneca Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AstraZeneca Nasal Spray Flu Vaccines Product Portfolio
  18. 6.3.5 AstraZeneca Recent Developments
  19. 6.4 Serum Institute of India
  20. 6.4.1 Serum Institute of India Company Information
  21. 6.4.2 Serum Institute of India Business Overview
  22. 6.4.3 Serum Institute of India Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum Institute of India Nasal Spray Flu Vaccines Product Portfolio
  24. 6.4.5 Serum Institute of India Recent Developments
  25. 6.5 Sanofi Pasteur
  26. 6.5.1 Sanofi Pasteur Company Information
  27. 6.5.2 Sanofi Pasteur Business Overview
  28. 6.5.3 Sanofi Pasteur Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Pasteur Nasal Spray Flu Vaccines Product Portfolio
  30. 6.5.5 Sanofi Pasteur Recent Developments
  31. 6.6 CSL
  32. 6.6.1 CSL Company Information
  33. 6.6.2 CSL Business Overview
  34. 6.6.3 CSL Nasal Spray Flu Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CSL Nasal Spray Flu Vaccines Product Portfolio
  36. 6.6.5 CSL Recent Developments
7 North America by Country
  1. 7.1 North America Nasal Spray Flu Vaccines Sales by Country
  2. 7.1.1 North America Nasal Spray Flu Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nasal Spray Flu Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nasal Spray Flu Vaccines Market Size by Country
  6. 7.2.1 North America Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nasal Spray Flu Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nasal Spray Flu Vaccines Sales by Country
  2. 8.1.1 Europe Nasal Spray Flu Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nasal Spray Flu Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nasal Spray Flu Vaccines Market Size by Country
  6. 8.2.1 Europe Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nasal Spray Flu Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nasal Spray Flu Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Nasal Spray Flu Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nasal Spray Flu Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nasal Spray Flu Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nasal Spray Flu Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nasal Spray Flu Vaccines Sales by Country
  2. 10.1.1 South America Nasal Spray Flu Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nasal Spray Flu Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nasal Spray Flu Vaccines Market Size by Country
  6. 10.2.1 South America Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nasal Spray Flu Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nasal Spray Flu Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Nasal Spray Flu Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nasal Spray Flu Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nasal Spray Flu Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nasal Spray Flu Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Nasal Spray Flu Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nasal Spray Flu Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nasal Spray Flu Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nasal Spray Flu Vaccines Value Chain Analysis
  2. 12.1.1 Nasal Spray Flu Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nasal Spray Flu Vaccines Production Mode & Process
  7. 12.2 Nasal Spray Flu Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nasal Spray Flu Vaccines Distributors
  10. 12.2.3 Nasal Spray Flu Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research